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Th e retina, essential in the visual function of the eyeball, is a light-sensitive 
neurosensory tissue located on the inner surface of the eyeball. Th e light that 
reaches the retina triggers a series of chemical and electrical phenomena that 
eventually result in nerve impulses that are sent to the brain through the optic 
nerve. Th is tissue, which is so important for the development and processing of 
vision, is not exempt from pathologies that can generate partial or total damage to 
its structure and which can compromise important areas such as the macula and 
its central area, the fovea. Th ere is a variety of pathologies that can aff ect the retina 
We will review the most common pathologies due to the characteristics of our 
population, nutrition, geographical situation and development.
We must remember that retinal pathologies can aff ect the persons in any age 
range, among them the most defenseless and with great visual development 
requirements such as newborns in a premature state. We will begin then with 
the Retinopathy of Prematurity (ROP), which is the main cause of blindness in 
childhood worldwide.1,2
Many changes in technology, science and clinical medicine have improved 
understanding of the pathogenesis of ROP. Technical advances in the ability to 
regulate the conditions of premature infants have improved the survival of them, 
even in extreme stages, with the increased risk for the development of this ocular 
pathology. ROP aff ects premature infants of low weight and early gestational 
age who, together with other systemic comorbidities, such as sepsis and oxygen 
saturation level, are the most important risk factors. Th e key pathological 
feature is local ischemia with subsequent retinal neovascularization.3 It has been 
recognized that ROP diff ers globally and that there is a need to consider diff erent 
treatment, screening and detection approaches, depending on the characteristics 
of the population. Th e early management of this pathology with laser is of great 
importance, as well as the intravitreal antiangiogenic therapies directed to reduce 
the aberrant vasoproliferation and facilitate the physiological retinal vascular 
development without damaging the visual development of the infant.2
Another important pathology in the routine ophthalmological clinical practice and 
especially of the retina specialist, is Rhegmatogenous Detachment of the Retina 
(RDD). RDD is a term we use to describe the separation of the neurosensory 
retina from the retinal pigment epithelium (RPE) due to a rupture or rhegma in 
the retina, oft en associated with traction mechanisms and the subsequent vitreous 
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entry liquefi ed through the retina. Th is pathology 
represents a risk in the general population of 0.8 per 
100,000 live people, which rises to between 5.4 - 18.2 in 
the population over 55 years old. Th e most important 
risk factors for the development of RDD are myopia, 
the history of having undergone surgery for cataract 
and eye trauma. 4,5 Its identifi cation and early surgical 
treatment are essential for a better visual prognosis, 
which will depend on macular involvement as well 
as the anatomical component; it is also infl uenced 
by the time of evolution of the RDD as well as the 
complexity of it. For this reason, the education and 
awareness of the population in the identifi cation of the 
initial symptoms will allow us to target and improve 
the prognosis of this disease as well as to perform the 
surgical treatment in its earliest stages.
Th e third pathology we will discuss is diabetic 
retinopathy (DR). DR is one of the most important 
causes of visual dysfunction in adults during their 
productive age. Th e prevalence of DR and secondary 
visual loss are increasing dramatically. Th e adequate 
education and systemic control of diabetic patients, 
maintaining glucose levels and blood pressure close 
to normal limits, reduces the risk of DR development 
and / or progression, which is why multidisciplinary 
management is essential in these patients. 
Microvascular damage to the retina due to DR leads 
to non-capillary retinal perfusion, microaneurysms, 
intraretinal hemorrhages, nerve fi ber layer infarcts, 
venous abnormalities, and intraretinal microvascular 
abnormalities (IRMA). In the same way, the increase 
in vascular permeability characteristic of this disease, 
leads to retinal thickening (edema) and / or exudates 
that can lead to a loss in central visual acuity. In the 
evolution and inappropriate control of the systemic 
disease, RD can evolve to a proliferative stage, due to the 
closure of arterioles and venules, with a proliferation 
of new secondary vessels in the disc, retina, iris and 
anterior chamber angle. Th is vasoproliferative state, 
can lead to tractional RD, vitreous hemorrhage, 
neovascular glaucoma and secondary blindness.6–8 
Among the tools for the treatment in the hands of the 
retina specialist we have, laser photocoagulation, still 
one of the pillars in the treatment of DR; Intravitreal 
injections of anti - VEGF agents, which are very 
eff ective in diabetic macular edema, proliferative DR, 
as well as in the involution of the disease. However, 
we cannot forget the surgical management, very 
important and effi  cient in more severe stages of the 
disease.6
Another pathology that we cannot fail to mention are 
retinal vein occlusions (RVO), pathology that presents 
an incidence of 2.3% in the general population. Of 
this percentage, 78% correspond to Branch retinal 
vein occlusion (BRVO) and 22 % to central retinal 
vein occlusions (CRVO). Th e prognosis of this 
pathology varies according to the site and degree 
of occlusion (ischemic or non-ischemic). Macular 
edema secondary to this pathology is an important 
cause of visual dysfunction. Th e proposed treatments 
for venous occlusions may include the use of laser 
photocoagulation, corticoids and intravitreal anti 
- VEGF. Th e risk factors include medical systemic 
conditions such as hypertension, diabetes mellitus, 
lipid and coagulation disorders, for this reason, the 
importance of detecting and educating the population 
at risk, as well as the early diagnosis of the pathology 
are essential to off er better visual health.9 
Finally, we have Age-Related Macular Degeneration 
(AMD), one of the main causes of severe and irreversible 
visual dysfunction in patients older than 65 years, a 
pathology responsible for 46% of cases of severe visual 
loss in people over 40 in the USA. Th e incidence, 
progression and associated characteristics of AMD 
increase with age, and likewise, the prevalence of this 
disease varies with ethnicity. Th e anatomopathological 
characteristics of AMD are the presence of drusen, 
which are cellular deposits of yellowish residues, 
located at the level of the Bruch membrane, below the 
RPE and the pigment of the macula. Th e disease can 
progress to more severe stages, a severe dry AMD with 
geographic atrophy, neovascular or wet AMD, stages 
that have a serious impact on visual acuity and are 
non-reversible. Although it is estimated that 80% of 
patients with AMD have a non-neovascular or atrophic 
AMD, the neovascular form is responsible for almost 
90% of the loss of severe visual acuity (≤20 / 200) due 
to AMD. Th e primary risk factors for the development 
of advanced AMD include increased age, race and 
genetic factors. Likewise, one of the most important 
modifi able risks is the cigarette. Th e use of vitamin 
antioxidants and mineral supplements identifi ed 
in the AREDS and AREDS 2 studies should be 
considered in patients with intermediate or advanced 
unilateral AMD. In patients with a wet AMD, early 
detection and timely treatment improves the visual 
result. Diagnostic tools such as Optical Coherence 
Tomography (OCT), OCT Angiography and Retinal 
Fluorescein Angiography are very important in the 
detection, follow-up and guidance in the treatment of 
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neovascular activity in AMD. Intravitreal treatment 
with anti - VEGF agents is the most eff ective way to 
manage the wet variety of the disease and represents 
the fi rst line of management.10,11
So, we have a variety of retinal diseases, which are 
part of the day to day of eye health in our country, 
and these can reduce the vision and quality of life of 
our population. Th e education, prevention, screening, 
consultation and treatment with the retina specialist 
in a timely manner would allow to identify these 
pathologies in time and provide patients with an 
adequate opportunity of attention and therefore 
a better visual prognosis. However, this does not 
happen. We found many retinal ocular pathologies 
sometimes undiagnosed or with wrong diagnoses, 
not attended by qualifi ed personnel, with inadequate 
referral times to the retina specialist and in many 
cases only attended in a delayed manner by the them, 
making their management more diffi  cult, costly and 
with dubious prognosis.
Th is mentioned dramatic situation is associated with 
low education of the communities, poor preparation 
of professionals, and the lack of use of prevention 
mechanisms by health insurance companies, which 
restrict and obstruct referrals to retina specialists and the 
taking of necessary auxiliary exams and technological 
procedures for the diagnosis and management of these 
pathologies. We have a signifi cant defi cit in the use of 
preventive medicine and the current policies of the 
government and health system are useless in directing 
and properly managing the body of the iceberg under 
which all our ophthalmological health problems and 
especially retinal diseases are found in our country.
Finally, it is important as ophthalmologists, to become 
aware of the reality in which we fi nd ourselves: we 
have a defective, unequal and selfi sh health system that 
off ers us, in general, a poor quality of visual health. 
Only then, we can demand what rightfully belongs to 
us, a quality visual health that is what every human 
being and every citizen of our beloved Colombia 
deserves.
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